Concepedia
Statistics
Publications
4
Citations
147
H-Index
Active since
2009
Affiliations
Institute of Cancer Research(Current)
Cancer Research UK
Suki Klair is an author at Institute of Cancer Research specializing in drug discovery, medicine, and pharmacology.
Top concepts
MedicinePharmacologyDrug DiscoveryBiochemistryMedicinal ChemistryHealthPhysiologyDrug ResistancePharmacotherapyChemical Biology
Publications per year
2009–2015
Structure-Guided Evolution of Potent and Selective CHK1 Inhibitors through Scaffold Morphing
John Reader, Thomas P. Matthews, Suki Klair et al. · Journal of Medicinal Chemistry · 2011 · 59 citations · Full text
Combinatorial Chemistry, Drug Target, Bioorganic Chemistry +18
Identification of Inhibitors of Checkpoint Kinase 1 through Template Screening
Thomas P. Matthews, Suki Klair, Samantha Burns et al. · Journal of Medicinal Chemistry · 2009 · 41 citations · Full text
Design and evaluation of 3,6-di(hetero)aryl imidazo[1,2-a]pyrazines as inhibitors of checkpoint and other kinases
Thomas P. Matthews, Tatiana McHardy, Suki Klair et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 29 citations · Full text
Medicinal Chemistry, Health Sciences, Medicine +8
Discovery of HTL6641, a dual orexin receptor antagonist with differentiated pharmacodynamic properties
J.A. Christopher, Sarah J. Aves, Jason Brown et al. · MedChemComm · 2015 · 18 citations
Efficacious Dual Antagonists, Novel Series, Biochemistry +12
1–4 of 4